Drug Profile
Research programme: G-protein coupled receptor antagonists - Proximagen
Latest Information Update: 28 May 2018
Price :
$50
*
At a glance
- Originator Proximagen
- Class Small molecules
- Mechanism of Action G protein-coupled receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Diabetic nephropathies
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Diabetic-nephropathies in United Kingdom